Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Gallium-68-DOTA-N-Octreotide[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
2Octreotide[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[7] 67, 75, 84, 85, 89, 193, 227 💬
3Octreotide a azione pronta 0,1 mg[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
4OCTREOTIDE ACETATE[2] Acetate,
Octreotide		[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
5OCTREOTIDE ACETATO[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
6Octreotide LAR[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 227 💬
7Octreotide LAR / Sandostatin LAR (LAR=long acting release)[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
8Octreotide-LAR[1] Octreotide[1] Octreotide 💬[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 67 💬